Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings crawled time : 00:00 save search
LogicMark, Inc. Reschedules Release of Fourth Quarter and Full Year 2023 Financial Results to April 1, 2024
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
LGMK | $0.864 -0.12% -0.12% 16K
|
Information
|
| O: 0.0%
H: 0.0%
C: -0.01%
year financial results
Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
OMER | $3.04 -1.62% -1.64% 250K
|
Health Technology
|
| O: 2.89%
H: 0.0%
C: -3.93%
corporation financial results
IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
ICCM | $1.22 0.82% 94K
|
Manufacturing
|
| O: -0.85%
H: 2.56%
C: 1.71%
report year medical financial results
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
SYRS | $5.055 -1.65% -1.68% 90K
|
Health Technology
|
| O: -4.8%
H: 3.7%
C: -1.85%
year update financial results
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
PDSB | $3.26 1.88% 1.84% 450K
|
Health Technology
|
| O: -10.71%
H: 8.5%
C: -3.75%
biotech year update financial results
Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
|
| O: 2.7%
H: 1.41%
C: 0.0%
year bioscience financial results
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
Published: 2024-03-25 (Crawled : 00:00) - biospace.com/
VNRX | $0.8 -5.88% 0.0% 350K
|
Health Technology
|
| O: 1.0%
H: 8.11%
C: -2.7%
business year update financial results
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
Published: 2024-03-25 (Crawled : 00:00) - biospace.com/
NBY | $0.0773 0.39% 0.0% 920K
|
Health Technology
|
| O: -1.54%
H: 1.42%
C: -3.88%
conference year pharmaceuticals
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
Published: 2024-03-25 (Crawled : 00:00) - biospace.com/
EQ | $1.8 4.65% 4.44% 110K
|
Health Technology
|
| O: -1.42%
H: 4.32%
C: -12.23%
year financial results
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024
Published: 2024-03-20 (Crawled : 00:00) - biospace.com/
DTIL | $9.81 -4.11% -4.28% 34K
|
Health Technology
|
| O: 0.0%
H: 3.33%
C: 1.92%
precision report year results
Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date
Published: 2024-03-20 (Crawled : 00:00) - biospace.com/
SLP | $46.64 1.39% 1.35% 100K
|
Technology Services
|
| O: -0.49%
H: 2.02%
C: 1.72%
conference year plus
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-03-20 (Crawled : 00:00) - biospace.com/
OABI | News | $4.56 -1.72% -1.75% 560K
|
|
| O: -0.76%
H: 4.02%
C: 3.63%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
business year financial results
Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results
Published: 2024-03-18 (Crawled : 00:00) - biospace.com/
ALPN | $64.57 0.03% 0.03% 1.2M
|
Health Technology
|
| O: 0.22%
H: 0.92%
C: -2.72%
year update sciences financial results
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
Published: 2024-03-18 (Crawled : 00:00) - biospace.com/
PURE | $0.08 1.01% 74K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -2.22%
bioscience financial results
LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Published: 2024-03-04 (Crawled : 00:00) - biospace.com/
LNSR | $3.18 0.31% 8.3K
|
Health Technology
|
| O: 6.38%
H: 6.0%
C: -3.4%
business lensar year update results
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-02-29 (Crawled : 00:00) - biospace.com/
NUVB | $2.66 -0.75% 0.0% 990K
|
|
| O: -2.03%
H: 4.4%
C: -3.11%
business year update financial results
Certara Reports Fourth Quarter 2023 Financial ResultsProvides Full Year 2024 Financial Guidance
Published: 2024-02-29 (Crawled : 00:00) - biospace.com/
CERT | $16.435 -1.76% -1.79% 420K
|
|
| O: 1.06%
H: 0.93%
C: -1.63%
year financial
Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-29 (Crawled : 00:00) - biospace.com/
QSI | $1.66 -2.35% -2.41% 440K
|
Professional, Scientific, and T...
|
| O: 3.45%
H: 3.33%
C: -7.22%
year financial results
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments
Published: 2024-02-28 (Crawled : 00:00) - biospace.com/
SRPT | $124.27 6.11% 5.75% 1.3M
|
Health Technology
|
| O: -0.28%
H: 1.03%
C: -2.58%
therapeutics financial results
Personalis Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-28 (Crawled : 00:00) - biospace.com/
PSNL | $1.3 -5.8% -6.15% 160K
|
Health Technology
|
| O: -4.0%
H: 4.17%
C: 1.39%
year financial results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.